3004.90.92 - Other
Sub-classifications
-
3004 9092 01
-
-
-
3004 9092 02
-
-
3004 9092 04
-
3004 9092 06
-
-
-
3004 9092 08
-
3004 9092 12
-
-
3004 9092 13
-
3004 9092 14
-
-
3004 9092 15
-
-
3004 9092 16
-
3004 9092 17
-
3004 9092 18
-
3004 9092 19
-
3004 9092 21
-
-
-
-
3004 9092 22
-
3004 9092 23
-
3004 9092 25
-
-
3004 9092 27
-
3004 9092 29
-
-
-
3004 9092 31
-
3004 9092 32
-
-
3004 9092 33
-
3004 9092 34
-
-
3004 9092 36
-
-
3004 9092 37
-
3004 9092 38
-
3004 9092 39
-
-
3004 9092 40
-
-
-
3004 9092 42
-
3004 9092 44
-
-
-
3004 9092 50
-
3004 9092 55
-
3004 9092 56
-
3004 9092 57
-
3004 9092 59
-
-
-
-
3004 9092 63
-
3004 9092 66
-
3004 9092 68
-
-
3004 9092 70
-
-
-
3004 9092 76
-
-
3004 9092 80
-
3004 9092 84
-
3004 9092 89
-
-
-
3004 9092 91
-
Overview
This classification, HTS Code 3004.90.92, pertains to medicaments containing mixed or unmixed products for therapeutic or prophylactic uses, specifically those not covered by headings 3002, 3005, or 3006. These products are presented in measured doses, such as tablets, capsules, or injections, or in forms suitable for direct retail sale. The "Other" designation indicates that these medicaments do not fall under specific sub-classifications within the broader medicaments category.
This category is distinguished from its sibling, 3004.90.10.00, which specifically covers medicaments containing antigens or hyaluronic acid or its sodium salt. Therefore, HTS Code 3004.90.92 applies to a wide range of pharmaceutical preparations for human or animal use that do not contain these specific components but still meet the criteria for medicaments in measured doses or retail packaging.
The subcategories under 3004.90.92 further refine the classification based on the intended recipient of the medicament. Specifically, a distinction is made for medicaments intended for veterinary use (3004.90.92.01). The remaining subcategory, also designated as "Other," encompasses those medicaments classified under 3004.90.92 that are not specifically for veterinary applications, thus covering the vast majority of human-use pharmaceuticals that meet the general criteria for this heading.